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P. Cao* and P. De RangoS.C. Chirurgia Vascolare, University of Perugia, Azienda Ospedaliera di Perugia, Perugia, ItalyDuring the past several years Carotid ultrasound has
assumed an even greater role in the diagnosis of
carotid stenosis and has been adopted as the first line
preoperative test. It is advisable that each ultrasound
laboratory should undertake regular validated com-
parisons between Duplex and angiography before
systematic Duplex practice, especially when new
machines or technologists arrive. Unfortunately,
there is no general consensus on what constitutes the
exact gold-standard for Duplex evaluation. This has
been evidenced by the survey described in the article
of Walker and Naylor published in this number of
EJVES.1 The Authors sent a questionnaire to assess
which Duplex criteria were most commonly used to
define carotid stenosis among members of the Society
of Vascular Technology of Great Britain and Ireland:
astonishingly, the majority of technologists did not
know which measurements method was used in their
unit. Furthermore, despite both the above countries
were the largest contributors to ECST, most of the
responders were using criteria that were more
consistent with a NASCET than an ECSTclassification.
In the face of redefinition of indications for carotid
revascularization, the attempt to identify which
Duplex criteria are mostly employed should be
appreciated and the use of a questionnaire is a
valuable tool.
The paper of Walker and Naylor confirms the value
that Audits and, to a larger extent, well conducted
Registries may have in providing useful information.
The most important messages provided by the
above paper can be summarized as follows:
(1) Despite several papers published shortly after the
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other studies, including the survey of Walker and
Naylor,1 have shown that the use of ultrasound as
the sole imaging techniques to establish the
indication for CEA has worldwide replaced the
utilization of other more expensive and risky
technologies without detriment for patients out-
come. This practice, in the attempt to decrease
invasiveness and complications of carotid revas-
cularization, has occurred in face of lack of
evidence-based data supporting this switching of
technologies. The issue may be even more
important in the perspective of comparing CEA
with carotid stenting (CAS), if and when, after the
necessary randomized trials, CAS will be con-
firmed as an alternative or even substitute for
CEA.
(2) Although the majority of respondents to Walker
and Naylor questionnaire did not know or
wrongly knew what measurements methods they
were using, it was clear that they were indeed
adopting PSV and EDV criteria validated by the
North American Consensus (i.e. NASCET
criteria).1
Of course,weshouldbeawareof the limitationsof the
information provided by the two authors: the number of
respondents was only 102 and we have no information
about the nonrespondents. On this regards it should be
remembered that although Audits and Registries are
important tools in depicting the ‘real world’, these have
important shortcomings due to the voluntary process of
registration, putting at risk the completeness of data and
the rate of follow-up overdues.
Secondly, information on if and how the used
methodology of the respondents reflects on the clinical
practice and particularly on surgical outcomes of each
individual center participating to the survey is not
provided, because this was out of the aim of the study.1Eur J Vasc Endovasc Surg 31, 491–492 (2006)
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the degree of carotid stenosis above which surgery is
beneficial (50% byNASCETor 70% by ECSTcriteria for
symptomatic stenosis, and 60% by ACAS criteria for
asymptomatic stenosis),3–5 an exact definition may not
be of crucial importance. When we reach the degree
for surgical benefit based on NASCET PSV/EDVor on
PSV/EDV of ECST or ACAS corresponding Duplex
criteria, the exact quantification of decile may be a
secondary tool: the very low complications rate after
CEA reported by most recent studies (!1%)6 may
balance the less benefit obtained in patients within
lower range of stenosis. Actually, analysis of pooled
data from ECST, NASCET and VA309 by Rothwell et
al., based on re-measuring and re-assessing carotid
angiogram with the same measurements and defi-
nitions, showed similar results, removing the uncer-
tainty that was generated by the disparities between
the originally reported results of the trials.7 These
findings suggest that definition of exact degree of
stenosis may only be a surrogate marker for outcomes.
The same can be applied for stenosis measured with
Duplex scan.
On the other hand, the lack of Duplex standardiz-
ation of the exact degree of stenosis may carry the risk
of over utilization of carotid treatment, especially in
case of asymptomatic stenosis in an era of rapidly
growing CAS.
In conclusion, more recent innovations in Duplex
and ultrasound imaging techniques and the improving
technology have led to a better understanding, careful
and simplified diagnostic procedures. So that, theEur J Vasc Endovasc Surg Vol 31, May 2006leading role of Duplex ultrasound in preoperative
and postoperative evaluation of carotid stenosis
appears strongly justified and needs validation in the
individual centre even if there is no universal
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